ESR1 and breast cancer: Here when comparing luminal tumors (ER+), the association between BC subtypes (both IHC-surrogate and molecular) and ratio values showed that tissues from BC patients with AR/PGR ≥ 1.54 have a significant trend to be classified as Luminal B when compared to Luminal A tumors (Figs. 3A and 4).